Management of the Zollinger-Ellison syndrome in pregnancy


      OBJECTIVE: There is almost no information on the management of patients with functional pancreatic endocrine tumors such as Zollinger-Ellison syndrome during pregnancy. The purpose of this study was to develop an approach for the management of such cases during pregnancy on the basis of experience with five recent cases. STUDY DESIGN: Five women with Zollinger-Ellison syndrome who had seven pregnancies were the subject of this study. Each patient had an initial evaluation to confirm the diagnosis and to establish gastrinoma location and for the presence or absence of multiple endocrine neoplasia type I. In patients with Zollinger-Ellison syndrome diagnosed before conception, various medical or surgical treatments were established before conception and were used to control acid secretion throughout the pregnancy. The presence of upper gastrointestinal symptoms during pregnancy, maternal and fetal complications, gender, and weight of the infant were determined in all cases. Acid control was determined in four of the five patients during six pregnancies. RESULTS: The interval between the onset of Zollinger-Ellison syndrome and the subsequent pregnancy varied from 0.6 to 9.9 years (mean 6.9 ± 1.7 years). Zollinger-Ellison syndrome was unrecognized before pregnancy in two patients (40%); it was diagnosed between 0.2 and 2.4 years after the pregnancy. In three patients the time of diagnosis varied from 2.6 to 9 years before pregnancy. All patients had symptoms from gastric hypersecretion and elevated fasting serum gastrin levels that varied from 20% above normal to 37-fold above normal with mean of 2536 pg/ml (range 124 to 6970 pg/ml). Four of the five patients (80%) had positive secretin and calcium provocative tests. Two patients had multiple endocrine neoplasia type I. The five patients had seven pregnancies. Acid secretion was treated during pregnancy with antacids only (one patient), ranitidine alone (one patient), prior curative gastrinoma resection (one patient, two pregnancies), prior parietal cell vagotomy with incomplete tumor resection (one patient, two pregnancies), and prior parathyroidectomy and use of ranitidine in a patient with multiple endocrine neoplasia type I. In five pregnancies in three of the cases, no gastric antisecretory medications were needed during pregnancy. The mean acid secretion during pregnancy was 11.9 mEq/hr (range 0 to 42 mEq/hr). In the two cases with poor acid control and unrecognized Zollinger-Ellison syndrome mild fetal complications occurred. CONCLUSIONS: It is possible for patients with Zollinger-Ellison syndrome to have pregnancies that are not complicated by gastric acid hypersecretion. If the Zollinger-Ellison syndrome is diagnosed before pregnancy, curative resection or resection with parietal cell vagotomy may obviate the need for gastric antisecretory drugs. If metastases are present or the diagnosis of Zollinger-Ellison syndrome is made after conception, ranitidine in the lowest possible dose should be used to control acid secretion. If acid secretion in uncontrolled, the dose may be increased or omeprazole may be used. (Am J Obstet Gynecol 1997;176:224-33.)


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jensen RT
        • Gardner JD.
        in: The pancreas: biology, pathobiology and disease. Raven, New York1993: 931-978
        • Ellison EH
        • Wilson SD.
        The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases.
        Ann Surg. 1964; 160: 512-530
        • Jensen RT
        • Norton JA.
        Endocrine tumors of the pancreas.
        in: 2nd ed. Textbook of gastroenterology. Lippincott, Philadelphia1995: 2131-2166
        • Metz DC
        • Jensen RT.
        Advances in gastric antisecretory therapy in Zollinger-Ellison syndrome.
        in: Endocrine tumors of the pancreas: recent advances in research and management. Volume 23: frontiers of gastrointestinal research. Karger, Basel1995: 240-257
        • Weber HC
        • Venzon DJ
        • Lin JT
        • et al.
        Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study.
        Gastroenterology. 1995; 108: 1637-1649
        • Fishbeyn VA
        • Norton JA
        • Benya RV
        • et al.
        Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach.
        Ann Intern Med. 1993; 119: 199-206
        • Orbuch M
        • Doppman JL
        • Strader DB
        • et al.
        Imaging for pancreatic endocrine tumor localization: recent advances.
        in: Endocrine tumors of the pancreas: recent advances in research and management. Volumn 23: frontiers of gastrointestinal research. Karger, Basel1995: 268-281
        • Sugg SL
        • Norton JA
        • Fraker DL
        • et al.
        A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas.
        Ann Surg. 1993; 218: 138-144
        • Gibril F
        • Reynolds JC
        • Doppman JL
        • et al.
        Somatostatin receptor scintigraphy: a prospective study of its sensitivity compared to other imaging modalities in detecting primary and metastatic gastrinomas.
        Ann Intern Med. 1996; 125: 26-34
        • Pisegna JR
        • Norton JA
        • Slimak GG
        • Metz DC
        • Maton PN
        • Jensen RT.
        Effects of curative resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
        Gastroenterology. 1992; 102: 767-778
        • Ellison EC
        • Carey LC
        • Sparks J
        • et al.
        Early surgical treatment of gastrinoma.
        Am J Med. 1987; 82: 17-24
        • Richardson CT
        • Peters MN
        • Feldman M
        • et al.
        Treatment of Zollinger-Ellison syndrome with exploratory laparotomy, proximal gastric vagotomy, and H2-receptor antagonists: a prospective study.
        Gastroenterology. 1985; 89: 357-367
        • Ching MS
        • Morgan DJ
        • Mihaly GW
        • Hardy KJ
        • Smallwood RA.
        Placental transfer of omeprazole in maternal and fetal sheep.
        Dev Pharmacol Ther. 1986; 9: 323-331
        • Dicke JM
        • Johnson RF
        • Henderson GI
        • Kuehl TJ
        • Schenker S.
        A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta.
        Am J Med Sci. 1988; 295: 198-206
        • Lewis JH
        • Weingold AB.
        The use of gastrointestinal drugs during pregnancy and lactation.
        Am J Gastroenterol. 1985; 80: 912-923
        • Baron TH
        • Richter JE.
        Gastroesophageal reflux disease in pregnancy.
        Gastroenterol Clin North Am. 1992; 21: 777-791
        • Anand S
        • Van Thiel DH.
        Prenatal and neonatal exposure to cimetidine results in gonadal and sexual dysfunction in adult males.
        Science. 1982; 218: 493-494
        • Parker S
        • Udani M
        • Gavaler JS
        • Van Thiel DH.
        Pre- and neonatal exposure to cimetidine but not ranitidine adversely affects adult sexual functioning of male rats.
        Neurobehav Toxicol Teratol. 1984; 6: 313-318
        • Jensen RT
        • Collen MJ
        • Allende HD
        • et al.
        Cimetidine-induced impotence and breast changes in patients with gastric hypersecretory states.
        N Engl J Med. 1983; 308: 883-887
        • Goh JTW
        • Flynn MB
        • Florin THJ.
        Active chronic peptic ulcer disease complicated by gastric outlet obstruction in pregnancy.
        Aust N Z J Obstet Gynaecol. 1993; 33: 1-89
        • Armentano G
        • Bracco PL
        • DiSilverio C.
        Ranitidine in the treatment of reflux oesophagitis in pregnancy.
        Clin Exp Obstet Gynecol. 1996; 16: 130-133
        • Harper MA
        • McVeigh JE
        • Thompson W
        • Ardill JES
        • Buchanan KD.
        Successful pregnancy in association with Zollinger-Ellison syndrome.
        Am J Obstet Gynecol. 1995; 173: 863-864
        • Adamo S
        • Carrara M
        • Azzurro M
        • Sartori G
        • Vita G
        • Chidini O.
        Omeprazole treatment during first month of pregnancy: a case report.
        Ital J Gastroenterol. 1993; 25: 1
        • Norton JA
        • Cornelius MJ
        • Doppmann JL
        • Maton PN
        • Gardner JD
        • Jensen RT.
        Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome and multiple endocrine neoplasia type I: a prospective study.
        Surgery. 1987; 102: 958-966
        • MacFarlane MP
        • Fraker DL
        • Alexander HR
        • Norton JA
        • Jensen RT.
        A prospective study of surgical resection of duodenal and pancreatic gastrinomas.
        Surgery. 1995; 118: 973-980